GlassScriptPhysician profile
Sophia C La
NPI 1033693981
$3,642.89
in general payments reported to CMS, 2019-2025
16 companies · $374 in 2025
The $374 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $471 · 2021: $264 · 2022: $818 · 2023: $848 · 2024: $413 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,635.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,635.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,060.38 | 2019-2025 | Precision 1, Total30, Precision7 |
| Bausch & Lomb Americas INC. | $684.89 | 2022-2025 | Infuse, Btod, Biotrue |
| Johnson & Johnson Vision Care, INC. | $327.56 | 2022-2025 | Acuvue |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $270.95 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $234.09 | 2023-2024 | Cequa |
| Biotissue Holdings INC. | $203.54 | 2022-2025 | |
| Carl Zeiss Meditec, INC. | $159.32 | 2020 | |
| Dompe US, INC. | $124.99 | 2023 | Oxervate |
| Glaukos Corporation | $124.92 | 2019 | |
| Kala Pharmaceuticals, INC. | $123.80 | 2021 | |
| Allergan, INC. | $113.17 | 2022 | |
| Rxsight INC | $105.78 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Injector Cartridge |
| Sight Sciences, INC. | $38.44 | 2020-2022 | |
| Avedro INC. | $29.94 | 2019 | |
| Johnson & Johnson Surgical Vision, INC. | $22.07 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shire North American Group INC | $19.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sophia La listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.